Journal of Surgical Research
Volume 153, Issue 2 , Pages 239-245 , 15 May 2009

Inhibition of Tissue Factor—Factor VIIa Proteolytic Activity Blunts Hepatic Metastasis in Colorectal Cancer

  • Philippe Zerbib, M.D.

      Affiliations

    • Inserm ERI-9, Faculté de Médecine Lille, France
    • Université de Lille 2, EA2693, Lille, France
    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Département de Chirurgie Digestive et Transplantation, Centre Hospitalier Régional Universitaire, Hôpital Huriez, 59037 Lille Cedex, France
    • ,
  • Alexandre Grimonprez

      Affiliations

    • Inserm ERI-9, Faculté de Médecine Lille, France
    • Université de Lille 2, EA2693, Lille, France
    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • ,
  • Delphine Corseaux, Ph.D.

      Affiliations

    • Inserm ERI-9, Faculté de Médecine Lille, France
    • Université de Lille 2, EA2693, Lille, France
    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • ,
  • Frederic Mouquet, M.D., Ph.D.

      Affiliations

    • Inserm ERI-9, Faculté de Médecine Lille, France
    • Université de Lille 2, EA2693, Lille, France
    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • ,
  • Bertrand Nunes, M.D.

      Affiliations

    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • ,
  • Lars C. Petersen, M.S., Ph.D., D.Sc.

      Affiliations

    • Haemostasis Biology, Novo Nordisk A/S, Denmark
    • ,
  • Sophie Susen, M.D., Ph.D.

      Affiliations

    • Inserm ERI-9, Faculté de Médecine Lille, France
    • Université de Lille 2, EA2693, Lille, France
    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • ,
  • Alexandre Ung

      Affiliations

    • Inserm ERI-9, Faculté de Médecine Lille, France
    • ,
  • Mohamed Hebbar, M.D., Ph.D.

      Affiliations

    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • ,
  • François René Pruvot, M.D.

      Affiliations

    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • ,
  • Jean Pierre Chambon, M.D.

      Affiliations

    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France
    • ,
  • Brigitte Jude, M.D., Ph.D.

      Affiliations

    • Inserm ERI-9, Faculté de Médecine Lille, France
    • Université de Lille 2, EA2693, Lille, France
    • Centre Hospitalier Régional Universitaire, Département de Chirurgie Digestive and Institut d'Hématologie-Transfusion, Lille, France

Received 23 January 2008

References 

  1. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51
  2. Majer M, Akerley W, Kuwada SK. Oncologists' current opinion on the treatment of colon carcinoma. Anticancer Agents Med Chem. 2007;7:492
  3. Eilertsen KE, Osterud B. Tissue factor: (Patho)physiology and cellular biology. Blood Coagul Fibrinolysis. 2004;15:521
  4. Hjortoe GM, Petersen LC, Albrektsen T, et al. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood. 2004;103:3029
  5. Chen J, Bierhaus A, Schiekofer S, et al. Tissue factor—A receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost. 2001;86:334
  6. Yu JL, May L, Lhotak V, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: Implications for tumor progression and angiogenesis. Blood. 2005;105:1734
  7. Lwaleed BA, Chisholm M, Francis JL. Urinary tissue factor levels in patients with breast and colorectal cancer. J Pathol. 1999;187:291
  8. Lykke J, Nielsen HJ. The role of tissue factor in colorectal cancer. Eur J Surg Oncol. 2003;29:417
  9. Nakasaki T, Wada H, Shigemori C, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol. 2002;69:247
  10. Seto S, Onodera H, Kaido T, et al. Tissue factor expression in human colorectal carcinoma: Correlation with hepatic metastasis and impact on prognosis. Cancer. 2000;88:295
  11. Shigemori C, Wada H, Matsumoto K, et al. Tissue factor expression and metastatic potential of colorectal cancer. Thromb Haemost. 1998;80:894
  12. Yu JL, May L, Klement P, et al. Oncogenes as regulators of tissue factor expression in cancer: Implications for tumor angiogenesis and anti-cancer therapy. Semin Thromb Hemost. 2004;30:21
  13. Amirkhosravi A, Meyer T, Chang JY, et al. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost. 2002;87:930
  14. Hembrough TA, Swartz GM, Papathanassiu A, et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res. 2003;63:2997
  15. Hu Z, Garen A. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Acad Sci USA. 2001;98:12180
  16. Mueller BM, Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest. 1998;101:1372
  17. Rao LV, Ezban M. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action. Blood Coagul Fibrinolysis. 2000;11(Suppl 1):S135
  18. Sorensen BB, Persson E, Freskgard PO, et al. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem. 1997;272:11863
  19. Carson SD. Continuous chromogenic tissue factor assay: Comparison to clot-based assays and sensitivity established using pure tissue factor. Thromb Res. 1987;47:379
  20. Chauffert B, Shimizu T, Caignard A, et al. Use of a specific monoclonal antibody for studying the liver metastatic invasion of a rat colon cancer. In Vivo. 1988;2:301
  21. Ghrib F, Leger P, Ezban M, et al. Anti-thrombotic and haemorrhagic effects of active site-inhibited factor VIIa in rats. Br J Haematol. 2001;112:506
  22. Mueller BM, Reisfeld RA, Edgington TS, et al. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA. 1992;89:11832
  23. Ngo CV, Picha K, McCabe F, et al. CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models. Int J Cancer. 2007;120:1261
  24. Ott I, Weigand B, Michl R, et al. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. Circulation. 2005;111:349
  25. Versteeg HH, Schaffner F, Kerver M, et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood. 2008;111:190
  26. Schluter K, Gassmann P, Enns A, et al. Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol. 2006;169:1064
  27. Ott I, Fischer EG, Miyagi Y, et al. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol. 1998;140:1241
  28. Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000;96:3302
  29. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol. 2005;25:1545
  30. Sorensen BB, Rao LV, Tornehave D, et al. Antiapoptotic effect of coagulation factor VIIa. Blood. 2003;102:1708
  31. Cirillo P, Cali G, Golino P, et al. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation. 2004;109:2911

PII: S0022-4804(08)00361-2

doi: 10.1016/j.jss.2008.05.014

Journal of Surgical Research
Volume 153, Issue 2 , Pages 239-245 , 15 May 2009

Article Tools

* Image Usage & Resolution